Dan Paterson
Chief Executive Officer chez VERASTEM, INC.
Fortune : 1 M $ au 31/03/2024
Profil
Daniel W.
Paterson is the founder of The DNA Repair Co. (founded in 2006) and On-Q-ity, Inc. (founded in 2009).
He held the title of President & Chief Executive Officer at The DNA Repair Co. from 2006 to 2009 and Chief Operating Officer at On-Q-ity, Inc. from 2009 to 2010.
Mr. Paterson's current job is at Verastem, Inc. where he started in 2011 and currently holds the title of President, Chief Executive Officer & Director.
Mr. Paterson's former jobs include Head-Global Strategy at IQVIA, Inc., Vice President-Marketing & Corporate Development at PharMetrics, Inc., Principal at OnCare, Inc., Principal at Axion Pharmaceuticals, Inc., and VP-Product Management & Business Development at CareTools, Inc.Mr. Paterson's education history includes an undergraduate degree from Boston University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VERASTEM, INC.
0,34% | 19/03/2024 | 86 490 ( 0,34% ) | 1 M $ | 31/03/2024 |
Postes actifs de Dan Paterson
| Sociétés | Poste | Début |
|---|---|---|
| VERASTEM, INC. | Chief Executive Officer | 01/08/2023 |
Anciens postes connus de Dan Paterson
| Sociétés | Poste | Fin |
|---|---|---|
On-Q-ity, Inc.
 On-Q-ity, Inc. Medical/Nursing ServicesHealth Services On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its circulating tumor cell technology will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. On-Q-ity's products and services are based on its unique and proprietary circulating tumor cell (CTC) technology which enables them to capture, count and characterize CTCs from a sample of patient blood. Through proprietary circulating tumor cell (CTC) and biomarker technology, they are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. They invite companies with complementary technologies, innovative biomarkers, and special expertise in its field to explore partnering relationships. | Founder | 01/01/2010 |
The DNA Repair Co.
 The DNA Repair Co. Medical/Nursing ServicesHealth Services The DNA Repair Co. develops cancer diagnostics solutions. The firm produces DNA Repair biomarkers which reveal therapeutic solutions for cancer drugs. The company was founded by Alan D’Andrea, William A. Haseltine, Michael B. Yaffe, and Markus Grompe and is headquartered in Boston, MA. | Chief Executive Officer | 03/11/2009 |
CareTools, Inc.
 CareTools, Inc. Packaged SoftwareTechnology Services Part of Aptiv Plc, CareTools, Inc. develops medical software. The private company is based in Seattle, WA. The company was founded by Thomas C. Giannulli. CareTools was acquired by DPH Medical Systems LLC on June 29, 2005. | Corporate Officer/Principal | - |
| IMS HEALTH, INC. | Corporate Officer/Principal | - |
OnCare, Inc.
 OnCare, Inc. Medical/Nursing ServicesHealth Services OnCare, Inc. was a oncology practice management and disease management company. The company provides management services to Texas Cancer Care. The company was headquarteerd in San Bruno, CA. | Corporate Officer/Principal | - |
Formation de Dan Paterson
| Boston University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| VERASTEM, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
IQVIA, Inc.
 IQVIA, Inc. Data Processing ServicesTechnology Services IQVIA, Inc. provides information technology solutions to the healthcare industry. It offers research and development, enterprise information management, commercial analytics, market analysis, patient consent system, content management, and other related solutions. The company was founded by Bill Frohlich and David Dubow in 1954 and is headquartered in Danbury, CT. | Technology Services |
PharMetrics, Inc.
 PharMetrics, Inc. Miscellaneous Commercial ServicesCommercial Services PharMetrics, Inc. provided healthcare market insights based on longitudinal and patient-centric information. The company was founded in 1998 and was headquartered in Watertown, MA. | Commercial Services |
The DNA Repair Co.
The DNA Repair Co. Medical/Nursing ServicesHealth Services The DNA Repair Co. develops cancer diagnostics solutions. The firm produces DNA Repair biomarkers which reveal therapeutic solutions for cancer drugs. The company was founded by Alan D’Andrea, William A. Haseltine, Michael B. Yaffe, and Markus Grompe and is headquartered in Boston, MA. | Health Services |
OnCare, Inc.
OnCare, Inc. Medical/Nursing ServicesHealth Services OnCare, Inc. was a oncology practice management and disease management company. The company provides management services to Texas Cancer Care. The company was headquarteerd in San Bruno, CA. | Health Services |
Axion Pharmaceuticals, Inc.
 Axion Pharmaceuticals, Inc. Electronic Equipment/InstrumentsElectronic Technology Axion Pharmaceuticals, Inc. provides cancer therapy products. It is headquartered in South San Francisco, CA. | Electronic Technology |
CareTools, Inc.
CareTools, Inc. Packaged SoftwareTechnology Services Part of Aptiv Plc, CareTools, Inc. develops medical software. The private company is based in Seattle, WA. The company was founded by Thomas C. Giannulli. CareTools was acquired by DPH Medical Systems LLC on June 29, 2005. | Technology Services |
On-Q-ity, Inc.
On-Q-ity, Inc. Medical/Nursing ServicesHealth Services On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its circulating tumor cell technology will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. On-Q-ity's products and services are based on its unique and proprietary circulating tumor cell (CTC) technology which enables them to capture, count and characterize CTCs from a sample of patient blood. Through proprietary circulating tumor cell (CTC) and biomarker technology, they are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. They invite companies with complementary technologies, innovative biomarkers, and special expertise in its field to explore partnering relationships. | Health Services |
